Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_assertion type Assertion NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_head.
- NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_assertion description "[Plasma CETP concentrations at baseline and after 2 years' treatment with pravastatin or placebo were measured (n=674), and correlations with lipid and angiographic parameters (mean segment- and obstruction-diameter; MSD and MOD), and TaqIB genotype were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_provenance.
- NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_assertion evidence source_evidence_literature NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_provenance.
- NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_assertion SIO_000772 14984434 NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_provenance.
- NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_assertion wasDerivedFrom befree-20140225 NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_provenance.
- NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_assertion wasGeneratedBy ECO_0000203 NP730322.RAWbSbfMm4JvKlFnc8SIVltUIAutSSquJGtbkuuSn5e0Q130_provenance.